Medical Cannabis Moved to Schedule III

In April 2026, two narrow categories moved to Schedule III: cannabis inside an FDA-approved drug, and marijuana under a qualifying state medical license. Everything else, including all adult-use cannabis, is still Schedule I DOJ Federal Register, 91 FR 22714. A qualifying state medical license means a license issued by a state, D.C., or territorial authority to manufacture, distribute, or dispense marijuana for medical purposes Federal Register, 91 FR 22714. The order does not create a federal medical program. It borrows each state’s existing definition, so what counts as medical in one state may not count in another, and a licensed operator must also register with the DEA to fall under Schedule III. The DEA registration cannot exceed the scope of the state license, and if the state license is suspended, revoked, or expires, the DEA registration is automatically suspended Federal Register, 91 FR 22714.

What is settled. Acting Attorney General Todd Blanche signed the final order on April 23, 2026, and it took effect April 28, 2026 DOJ Federal Register, 91 FR 22714. The same order opened a separate, expedited hearing on whether the whole plant should move. That question is still undecided.

What changes for now. Section 280E of the tax code denies normal business deductions to any business that sells a Schedule I or II drug. Schedule III sits outside 280E, so a covered medical operation can now deduct rent, payroll, and other ordinary costs like any other business. Whitney Economics estimates 280E cost operators about $2.24 billion in excess federal tax in 2025 alone Whitney Economics, via Yahoo Finance. Beyond tax, DEA-registered researchers can now source flower, extracts, and other product forms directly from state-licensed businesses that are themselves DEA-registered, and the DEA opened a medical marijuana dispensary registration portal on April 29, 2026 The Cannigma. Covered operators also come under federal DEA oversight for the first time, including registration, recordkeeping, security, and inventory requirements Federal Register, 91 FR 22714. A broader move after the whole-plant hearing would extend the same changes further. A denial would leave them where they stand.

What does not change. Schedule III is not legalization. The order does not open interstate commerce, and it does not change the federal status of any adult-use business Cannabis Regulations AI. Adult-use sales remain Schedule I activity, still inside 280E, with no deduction relief. Banking and card networks stay closed, and insurance reimbursement is not automatic The Cannigma.

Where serious people disagree. One side says this is the first time any state-licensed marijuana has left Schedule I since the Controlled Substances Act passed, and that the tax relief alone keeps covered medical operators solvent. The other side says the order mostly rewards large multi-state operators and pharma companies positioned to work the medical pathway, leaves adult-use businesses where they were, and delivered less than much of the industry expected Baked In / Dales Report. Consumer advocates at NORML say patients and consumers were not given a seat at the hearing NORML. On July 2, 2026, the National Drug and Alcohol Screening Association and MMJ International Holdings, a pharmaceutical company, asked the U.S. Court of Appeals for the D.C. Circuit to pause the rescheduling, and the Justice Department answered that both lacked standing and that their opposition reflects “pocketbook interests served by keeping all marijuana in schedule I”: a drug-testing industry protecting screening revenue, and a drug company blocking competition Marijuana Moment.

What is still open. The administrative hearing on whether the rest of the plant moves ran June 29 to July 15, 2026, before Chief Administrative Law Judge Derek C. Julius VapeExperts. Post-hearing briefs are due August 17, 2026, and no statute sets a deadline for the final decision VapeExperts. Separately, prohibitionist groups including SAM Inc. and the National Drug and Alcohol Screening Association sued to block the April order, a case now before the D.C. Circuit NORML. Either track could delay or unwind the April order, and the broader question could go either way.

If you have a source that sharpens or corrects any number here, post it. We will update and note the change.

The same flower, grown in the same facility, is Schedule III when it moves under a qualifying state medical license and Schedule I when it sells to an adult-use customer Federal Register, 91 FR 22714.